Katelyn T Byrne

7PUBLICATIONS
51CO-AUTHORS
Tumour immunologyInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 24, 2026
IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma.

|Nov 24, 2025
Tumor-intrinsic MHC-II activation in pancreatic ductal adenocarcinoma enhances immune response and treatment efficacy.

Canping Chen, Kyle P Gribbin, Xi Li

|Sep 30, 2025
CD4+ T Cells Mediate MHC-Deficient Tumor Rejection and Endothelial Cell Reprogramming.

Samuel I Kim, Margaret E Haerr, Maryam Al-Ghezi

|Aug 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic Cancer.

Jennifer M Finan, Yifei Guo, Alexandra Q Bartlett

|Feb 20, 2025
Pancreatic cancer-intrinsic HuR regulates the pro-tumorigenic properties of extracellular vesicles.

Jennifer M Finan, Yifei Guo, Alexandra Q Bartlett

|Feb 21, 2024
Machine Learning Links T-cell Function and Spatial Localization to Neoadjuvant Immunotherapy and Clinical Outcome in Pancreatic Cancer.

Katie E Blise, Shamilene Sivagnanam, Courtney B Betts

Pageof 2

Frequent Collaborators

5 joint publications

Zheng Xia

4 joint publications

Canping Chen

3 joint publications

Rosalie C Sears

3 joint publications

Margaret Haerr